bisbenzimidazole has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In these cells and in chronic lymphocytic leukemia cells obtained from patients, there was considerable intercell heterogeneity in apparent adduct levels." | 1.29 | Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells. ( Frank, AJ; Proctor, SJ; Tilby, MJ, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, AJ | 1 |
| Proctor, SJ | 1 |
| Tilby, MJ | 1 |
1 other study available for bisbenzimidazole and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells.
Topics: Antineoplastic Agents, Alkylating; Bisbenzimidazole; DNA Adducts; DNA, Neoplasm; Feasibility Studies | 1996 |